Mesh : Humans Vancomycin / therapeutic use Anti-Bacterial Agents / therapeutic use Intensive Care Units, Neonatal Infant, Newborn Sepsis / drug therapy Methicillin-Resistant Staphylococcus aureus / drug effects Staphylococcal Infections / drug therapy Practice Guidelines as Topic Retrospective Studies Neonatal Sepsis / drug therapy

来  源:   DOI:10.1097/INF.0000000000004172

Abstract:
A vancomycin-sparing guideline for suspected late-onset sepsis helped reduce vancomycin usage in our level-4 neonatal intensive care unit. Significant reduction in overall vancomycin use, with its likely unit-wide beneficial downstream effects, may need to be measured against the rare case of methicillin-resistant Staphylococcus aureus infection and delayed effective therapy.
摘要:
在我们的4级新生儿重症监护病房中,疑似晚发性败血症的保留万古霉素的指南有助于减少万古霉素的使用。万古霉素使用总量显著减少,由于其可能对整个单位有利的下游影响,可能需要针对罕见的耐甲氧西林金黄色葡萄球菌感染和延迟有效治疗进行测量。
公众号